Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to $74.9 million.

  • Core Laboratories' Cost of Revenue fell 80.39% to $74.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $295.1 million, marking a year-over-year decrease of 7.89%. This contributed to the annual value of $297.3 million for FY2024, which is 538.36% up from last year.
  • As of Q3 2025, Core Laboratories' Cost of Revenue stood at $74.9 million, which was down 80.39% from $74.1 million recorded in Q2 2025.
  • Over the past 5 years, Core Laboratories' Cost of Revenue peaked at $75.5 million during Q3 2024, and registered a low of $67.6 million during Q3 2022.
  • Over the past 4 years, Core Laboratories' median Cost of Revenue value was $72.1 million (recorded in 2023), while the average stood at $71.9 million.
  • As far as peak fluctuations go, Core Laboratories' Cost of Revenue soared by 946.27% in 2024, and later plummeted by 119.81% in 2025.
  • Core Laboratories' Cost of Revenue (Quarter) stood at $69.7 million in 2022, then rose by 2.08% to $71.1 million in 2023, then rose by 2.85% to $73.1 million in 2024, then grew by 2.41% to $74.9 million in 2025.
  • Its Cost of Revenue was $74.9 million in Q3 2025, compared to $74.1 million in Q2 2025 and $73.0 million in Q1 2025.